Menu
Back to User profile » Dr Claudie Charbonneau
Papers published by Dr Claudie Charbonneau:
Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System
Torres A, Soriano A, Rivolo S, Remak E, Peral C, Kantecki M, Ansari W, Charbonneau C, Hammond J, Grau S, Wilcox M
ClinicoEconomics and Outcomes Research 2022, 14:149-161
Published Date: 18 March 2022
Cost-effectiveness analysis of voriconazole, fluconazole, and amphotericin B for invasive fungal infections following allogeneic hematopoietic stem cell transplantation in Mexico
Morfín-Otero R, Alvarado-Ibarra M, Rodriguez-Noriega E, Resendiz-Sanchez J, Patel DA, Stephens JM, Di Fusco M, Mendoza CF, Charbonneau C
ClinicoEconomics and Outcomes Research 2018, 10:511-520
Published Date: 6 September 2018
Burden and treatment patterns of invasive fungal infections in hospitalized patients in the Middle East: real-world data from Saudi Arabia and Lebanon
Alothman AF, Althaqafi AO, Matar MJ, Moghnieh R, Alenazi TH, Farahat FM, Corman S, Solem CT, Raghubir N, Macahilig C, Charbonneau C, Stephens JM
Infection and Drug Resistance 2017, 10:35-41
Published Date: 2 February 2017
Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain
Grau S, Azanza JR, Ruiz I, Vallejo C, Mensa J, Maertens J, Heinz WJ, Barrueta JA, Peral C, Mesa FJ, Barrado M, Charbonneau C, Rubio-Rodríguez D, Rubio-Terrés C
ClinicoEconomics and Outcomes Research 2017, 9:39-47
Published Date: 30 December 2016
Economic analysis of empiric versus diagnostic-driven strategies for immunocompromised patients with suspected fungal infections in the People's Republic of China
Mao NY, Lesher B, Liu QF, Qin L, Chen YX, Gao X, Earnshaw SR, McDade CL, Charbonneau C
ClinicoEconomics and Outcomes Research 2016, 8:275-285
Published Date: 14 June 2016
An economic model to compare linezolid and vancomycin for the treatment of confirmed methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany
Patel DA, Michel A, Stephens J, Weber B, Petrik C, Charbonneau C
Infection and Drug Resistance 2014, 7:273-280
Published Date: 24 October 2014